Literature DB >> 31662554

Dosimetric Comparison of Sequential Versus Simultaneous-integrated Boost in Early-stage Breast Cancer Patients Treated With Breast-conserving Surgery.

Cem Onal1, Esma Efe2, Ozan C Guler2, Berna A Yildirim2.   

Abstract

BACKGROUND/AIM: To compare simultaneous-integrated boost (SIB) versus sequential-boost (SB) delivered in the context of whole-breast irradiation (WBI) via volumetric-modulated arc therapy (VMAT) and helical-tomotherapy (HT).
MATERIALS AND METHODS: Planning target-volume (PTV) dosimetric parameters and organs at risk (OAR) were analyzed for SB plan (50 Gy plus 16 Gy boost) and SIB plan (50.4 Gy WBI and 64.4 Gy tumor bed boost) in VMAT and HT techniques.
RESULTS: Conformity and homogeneity for target-volume doses were better in HT plans compared to VMAT plans. There were no significant differences in ipsilateral lung doses between VMAT and HT plans for SB/SIB techniques, except for a significantly higher lung V5 value with VMAT-SB, and lung V13 value with HT-SIB technique. HT provided a statistically significant decrease in contralateral lung mean V5.
CONCLUSION: The SIB technique showed better target-volume dose distribution in both HT and VMAT plans, and better sparing heart in HT compared to the SB technique. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Breast cancer; helical tomotherapy; radiotherapy; simultaneous integrated boost; volumetric-modulated arc therapy

Mesh:

Year:  2019        PMID: 31662554      PMCID: PMC6899153          DOI: 10.21873/invivo.11720

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  31 in total

Review 1.  Radiation dose-volume effects in the heart.

Authors:  Giovanna Gagliardi; Louis S Constine; Vitali Moiseenko; Candace Correa; Lori J Pierce; Aaron M Allen; Lawrence B Marks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

2.  High-dose simultaneously integrated breast boost using intensity-modulated radiotherapy and inverse optimization.

Authors:  Coen W Hurkmans; Gert J Meijer; Corine van Vliet-Vroegindeweij; Maurice J van der Sangen; Jorien Cassee
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-08-14       Impact factor: 7.038

3.  Volumetric modulated arc therapy: IMRT in a single gantry arc.

Authors:  Karl Otto
Journal:  Med Phys       Date:  2008-01       Impact factor: 4.071

4.  Incidence and Mortality and Epidemiology of Breast Cancer in the World.

Authors:  Mahshid Ghoncheh; Zahra Pournamdar; Hamid Salehiniya
Journal:  Asian Pac J Cancer Prev       Date:  2016

5.  Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer.

Authors:  Yasser Abo-Madyan; Muhammad Hammad Aziz; Moamen M O M Aly; Frank Schneider; Elena Sperk; Sven Clausen; Frank A Giordano; Carsten Herskind; Volker Steil; Frederik Wenz; Gerhard Glatting
Journal:  Radiother Oncol       Date:  2014-01-17       Impact factor: 6.280

6.  Long-term cosmetic changes after breast-conserving treatment of patients with stage I-II breast cancer and included in the EORTC 'boost versus no boost' trial.

Authors:  J M Immink; H Putter; H Bartelink; J S Cardoso; M J Cardoso; M H V van der Hulst-Vijgen; E M Noordijk; P M Poortmans; C C Rodenhuis; H Struikmans
Journal:  Ann Oncol       Date:  2012-04-12       Impact factor: 32.976

7.  Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial.

Authors:  Harry Bartelink; Jean-Claude Horiot; Philip M Poortmans; Henk Struikmans; Walter Van den Bogaert; Alain Fourquet; Jos J Jager; Willem J Hoogenraad; S Bing Oei; Carla C Wárlám-Rodenhuis; Marianne Pierart; Laurence Collette
Journal:  J Clin Oncol       Date:  2007-06-18       Impact factor: 44.544

8.  Adjuvant breast radiotherapy using a simultaneous integrated boost: clinical and dosimetric perspectives.

Authors:  Simone L Alford; Georgina N Prassas; Cathy R Vogelesang; Heather J Leggett; Chris S Hamilton
Journal:  J Med Imaging Radiat Oncol       Date:  2013-03-26       Impact factor: 1.735

9.  A treatment planning study comparing Elekta VMAT and fixed field IMRT using the varian treatment planning system eclipse.

Authors:  Samuel Peters; Hans Schiefer; Ludwig Plasswilm
Journal:  Radiat Oncol       Date:  2014-07-10       Impact factor: 3.481

10.  A comparative dosimetric study of left sided breast cancer after breast-conserving surgery treated with VMAT and IMRT.

Authors:  Hongfu Zhao; Mingyuan He; Guanghui Cheng; Dongmei Han; Ning Wu; Dan Shi; Zhipeng Zhao; Jianxue Jin
Journal:  Radiat Oncol       Date:  2015-11-17       Impact factor: 3.481

View more
  3 in total

1.  Lack of Relevant Haemogram Changes During Percutaneous Radiotherapy of Localised Prostate Cancer.

Authors:  Felix Zwicker; Benedict Swartman; Peter E Huber; Klaus Herfarth; Jürgen Debus; Henrik Hauswald
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  Comparison of Heart and Lung Doses According to Tumor Bed Boost Techniques in Early-Stage Left-Sided Breast Cancer: Simultaneous Integrated Boost versus Sequential Boost.

Authors:  Myungsoo Kim; Nam Kwon Lee; Suk Lee; Jinho Hwang
Journal:  Medicina (Kaunas)       Date:  2022-06-29       Impact factor: 2.948

3.  A comparative study on hypofractionated whole-breast irradiation with sequential or simultaneous integrated boost on different positions after breast-conserving surgery.

Authors:  Ting Yu; Yankang Li; Tao Sun; Min Xu; Wei Wang; Qian Shao; Yingjie Zhang; Jianbin Li; Jinming Yu
Journal:  Sci Rep       Date:  2021-09-09       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.